Cargando…
Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
Alzheimer’s disease (AD) is a common chronic and destructive disease. The early diagnosis of AD is difficult, thus the need for clinically applicable biomarkers development is growing rapidly. There are many methods to biomarker discovery and identification. In this review, we aim to summarize Mass...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057708/ https://www.ncbi.nlm.nih.gov/pubmed/24806343 http://dx.doi.org/10.3390/ijms15057865 |